FR2221728B1 - - Google Patents

Info

Publication number
FR2221728B1
FR2221728B1 FR7407245A FR7407245A FR2221728B1 FR 2221728 B1 FR2221728 B1 FR 2221728B1 FR 7407245 A FR7407245 A FR 7407245A FR 7407245 A FR7407245 A FR 7407245A FR 2221728 B1 FR2221728 B1 FR 2221728B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7407245A
Other languages
French (fr)
Other versions
FR2221728A1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of FR2221728A1 publication Critical patent/FR2221728A1/fr
Application granted granted Critical
Publication of FR2221728B1 publication Critical patent/FR2221728B1/fr
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/57—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
    • C07C45/58—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in three-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/32—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by aldehydo- or ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/60—Two oxygen atoms, e.g. succinic anhydride
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/12—Nitrate to nitrite reducing bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Furan Compounds (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Luminescent Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7407245A 1973-03-05 1974-03-04 Expired FR2221728B1 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33801973A 1973-03-05 1973-03-05

Publications (2)

Publication Number Publication Date
FR2221728A1 FR2221728A1 (enExample) 1974-10-11
FR2221728B1 true FR2221728B1 (enExample) 1976-10-15

Family

ID=23323052

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7407245A Expired FR2221728B1 (enExample) 1973-03-05 1974-03-04

Country Status (15)

Country Link
JP (1) JPS5443571B2 (enExample)
AT (1) AT332545B (enExample)
AU (1) AU473159B2 (enExample)
BE (1) BE811825A (enExample)
CA (1) CA1022483A (enExample)
CH (1) CH602905A5 (enExample)
DD (1) DD111374A5 (enExample)
DE (1) DE2407899C3 (enExample)
ES (1) ES423853A1 (enExample)
FR (1) FR2221728B1 (enExample)
GB (1) GB1433093A (enExample)
IL (1) IL44165A (enExample)
IT (1) IT1015815B (enExample)
NL (1) NL156509B (enExample)
NO (1) NO750485L (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4013658A (en) 1975-07-03 1977-03-22 Eli Lilly And Company Synthesis of 3,5-diphenyl-4(1h)-pyridazinones
GB1573212A (en) * 1976-04-15 1980-08-20 Technicon Instr Immunoassay for gentamicin
EP0011107B1 (de) * 1978-11-10 1983-06-22 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Methode zur Bestimmung einer Amino- oder Aminosulfonsäure
KR102385099B1 (ko) 2017-06-30 2022-04-12 주식회사 만도 전자식 브레이크 시스템 및 제어 방법

Also Published As

Publication number Publication date
GB1433093A (en) 1976-04-22
JPS5443571B2 (enExample) 1979-12-20
DE2407899B2 (de) 1978-02-16
DD111374A5 (enExample) 1975-02-12
IL44165A (en) 1977-06-30
IL44165A0 (en) 1974-05-16
AU6534074A (en) 1975-08-07
JPS49134670A (enExample) 1974-12-25
CH602905A5 (enExample) 1978-08-15
FR2221728A1 (enExample) 1974-10-11
AU473159B2 (en) 1976-06-17
NL7402645A (enExample) 1974-09-09
NO750485L (enExample) 1974-09-06
DE2407899A1 (de) 1974-09-19
NL156509B (nl) 1978-04-17
ES423853A1 (es) 1976-03-16
ATA174174A (de) 1976-01-15
AT332545B (de) 1976-10-11
CA1022483A (en) 1977-12-13
IT1015815B (it) 1977-05-20
DE2407899C3 (de) 1978-09-28
BE811825A (fr) 1974-09-04

Similar Documents

Publication Publication Date Title
AR201758A1 (enExample)
AU476761B2 (enExample)
AR201235Q (enExample)
AR201231Q (enExample)
AU474593B2 (enExample)
AU465453B2 (enExample)
AU471343B2 (enExample)
AU450229B2 (enExample)
AU476714B2 (enExample)
AR201229Q (enExample)
AU466283B2 (enExample)
AU476696B2 (enExample)
AU472848B2 (enExample)
AR199451A1 (enExample)
JPS5443571B2 (enExample)
AU476873B1 (enExample)
AR193950A1 (enExample)
AR210729A1 (enExample)
AU471461B2 (enExample)
AR195311A1 (enExample)
AR200885A1 (enExample)
AR195948A1 (enExample)
AR200256A1 (enExample)
AR197627A1 (enExample)
AU477824B2 (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse